Lab21 Acquires MDx Firm | GenomeWeb

NEW YORK (GenomeWeb News) – Lab21, a Cambridge, UK-based clinical lab and companion diagnostics developer, has purchased a majority share of molecular diagnostics firm Biotec Laboratories.

The Ipswich, UK-based diagnostics firm has focused on infectious diseases since its creation in 1993. It also has been distributing some of Lab21's diagnostics products through its global network of distributors in 80 countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.